PAVmed Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.37 | -$0.87 | -$1.67 |
| Q2 2024 | 1 | -$2.06 | -$0.76 | -$1.45 |
| Q3 2024 | 1 | $1.03 | $2.79 | $1.98 |
| Q4 2024 | 1 | -$0.81 | -$0.30 | -$0.57 |
| Q1 2025 | 1 | -$0.50 | -$0.18 | -$0.35 |
| Q2 2025 | 1 | -$0.45 | -$0.17 | -$0.32 |
| Q3 2025 | 1 | -$0.45 | -$0.17 | -$0.32 |
| Q4 2025 | 1 | -$0.24 | -$0.09 | -$0.17 |
PAVmed Inc. Earnings Date And Information
PAVmed Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.84 earnings per share for the quarter, topping analysts' consensus estimates of $-1.45 by $0.61. The company had revenue of 996.00 M for the quarter and had revenue of 2.45 M for the year. PAVmed Inc. has generated $-9 earnings per share over the last year ($-9.16 diluted earnings per share) and currently has a price-to-earnings ratio of 0.16. PAVmed Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
PAVmed Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | $6.43 | $1.09 M | $996.00 M | ||
| 08/12/2024 | Q2 2024 | -$1.19 | $1.20 M | $979,000 | ||
| 05/13/2024 | Q1 2024 | -$1.67 | -$2.62 | -0.95 | $1.01 M | |
| 03/25/2024 | Q4 2023 | -$1.98 | $1.05 M | |||
| 11/13/2023 | Q3 2023 | -$2.38 | $658,000 | $791,000 | ||
| 08/14/2023 | Q2 2023 | -$2.10 | $525,000 | $166,000 | ||
| 05/15/2023 | Q1 2023 | -$2.78 | $446,000 | |||
| 03/13/2023 | Q4 2022 | -$0.25 | -$3.31 | -3.06 | $112,000 | |
| 11/14/2022 | Q3 2022 | -$4.38 | $233,333 | $76,000 | ||
| 08/15/2022 | Q2 2022 | -$4.42 | $262,500 | $0 | ||
| 05/16/2022 | Q1 2022 | -$2.94 | $189,000 | |||
| 04/05/2022 | Q4 2021 | -$3.00 | $300,000 | |||
| 11/22/2021 | Q3 2021 | -$0.13 | -$2.21 | -2.08 | $275,000 | $200,000 |
| 08/16/2021 | Q2 2021 | -$2.11 | $126,667 | $0 | ||
| 05/17/2021 | Q1 2021 | -$0.12 | -$1.93 | -1.81 | $0 | |
| 03/15/2021 | Q4 2020 | -$2.49 | $0 | |||
| 11/06/2020 | Q3 2020 | -$1.72 | $0 | |||
| 08/14/2020 | Q2 2020 | -$1.89 | $0 | |||
| 05/28/2020 | Q1 2020 | -$5.02 | $0 | |||
| 04/24/2020 | Q4 2019 | -$2.86 | $0 |
PAVmed Inc. Earnings: Frequently Asked Questions
-
When is PAVmed Inc.'s earnings date?
PAVmed Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did PAVmed Inc. beat their earnings estimates last quarter?
In the previous quarter, PAVmed Inc. (:PAVM) reported $-0.84 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.45 by $0.61.
-
How can I listen to PAVmed Inc.'s earnings conference call?
The conference call for PAVmed Inc.'s latest earnings report can be listened to online.
-
How can I read PAVmed Inc.'s conference call transcript?
The conference call transcript for PAVmed Inc.'s latest earnings report can be read online.
-
How much revenue does PAVmed Inc. generate each year?
PAVmed Inc. (:PAVM) has a recorded annual revenue of $2.45 M.
-
How much profit does PAVmed Inc. generate each year?
PAVmed Inc. (:PAVM) has a recorded net income of $2.45 M. PAVmed Inc. has generated $-9.16 earnings per share over the last four quarters.
-
What is PAVmed Inc.'s price-to-earnings ratio?
PAVmed Inc. (:PAVM) has a price-to-earnings ratio of 0.16 and price/earnings-to-growth ratio is 0.
